Quantcast

Synovial Sarcoma - Online Support Group

NC-6300 (Nanoparticle Epirubicin)


#1

A new trial, not yet open to recruitment, will test a new way to deliver Epirubicin to sarcoma cells that may be less cardiotoxic and more efficient:


A phase 1 trial for solid tumor was already performed:

Here are some early articles on NC-6300: